This is highly speculative because: Oral bioavailability differs between species Route of administration affects systemic exposure Species differences in peptide metabolism and clearance are unknown Current Practice Patterns Current practice patterns from unregulated sources typically involve: Subcutaneous injection: 0.25-0.5 mg once or twice daily, administered near injection sites for localized effects or abdominally for systemic distribution
Peng, C
Its all-natural and more affordable than oral medications, topical creams and treatments and surgeries, which can cost $15,000 for a full transplant
"While these arrangements are not inherently anti-competitive, we recognize the increased scrutiny in this area and the importance of ensuring they are used appropriately," Empire said in a statement
Finally, the review notes that a couple of clinical studies on TB4 for wound healing both resulted in the peptide accelerating the healing process.21 March 2024 study Interestingly, in a 2024 study, researchers found that TB-500 (Ac-LKKTETQ) didnt increase wound-healing activity, but one of its metabolites Ac-LKKTE did